These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 36765583)

  • 21. Validation and evaluation of clinical prediction systems for first and repeated transarterial chemoembolization in unresectable hepatocellular carcinoma: A Chinese multicenter retrospective study.
    Wang ZX; Wang EX; Bai W; Xia DD; Mu W; Li J; Yang QY; Huang M; Xu GH; Sun JH; Li HL; Zhao H; Wu JB; Yang SF; Li JP; Li ZX; Zhang CQ; Zhu XL; Zheng YB; Wang QH; Li J; Yuan J; Li XM; Niu J; Yin ZX; Xia JL; Fan DM; Han GH; On Behalf Of China Hcc-Tace Study Group
    World J Gastroenterol; 2020 Feb; 26(6):657-669. PubMed ID: 32103874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic role of multiparameter MRI and radiomics in progression of advanced unresectable hepatocellular carcinoma following combined transcatheter arterial chemoembolization and lenvatinib therapy.
    Luo J; Huang Z; Wang M; Li T; Huang J
    BMC Gastroenterol; 2022 Mar; 22(1):108. PubMed ID: 35260095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting early refractoriness of transarterial chemoembolization in patients with hepatocellular carcinoma using a random forest algorithm: A pilot study.
    Zou ZM; An TZ; Li JX; Zhang ZS; Xiao YD; Liu J
    J Cancer; 2021; 12(23):7079-7087. PubMed ID: 34729109
    [No Abstract]   [Full Text] [Related]  

  • 24. Explainable Machine Learning Model to Prediction EGFR Mutation in Lung Cancer.
    Yang R; Xiong X; Wang H; Li W
    Front Oncol; 2022; 12():924144. PubMed ID: 35814445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lenvatinib plus transarterial chemoembolization with or without immune checkpoint inhibitors for unresectable hepatocellular carcinoma: A review.
    Sun L; Xu X; Meng F; Liu Q; Wang H; Li X; Li G; Chen F
    Front Oncol; 2022; 12():980214. PubMed ID: 36249023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of low cardiac output syndrome in patients following cardiac surgery using machine learning.
    Hong L; Xu H; Ge C; Tao H; Shen X; Song X; Guan D; Zhang C
    Front Med (Lausanne); 2022; 9():973147. PubMed ID: 36091676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of intraoperative red blood cell transfusion in valve replacement surgery: machine learning algorithm development based on non-anemic cohort.
    Zhou R; Li Z; Liu J; Qian D; Meng X; Guan L; Sun X; Li H; Yu M
    Front Cardiovasc Med; 2024; 11():1344170. PubMed ID: 38486703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transarterial chemoembolization plus lenvatinib with or without programmed death-1 inhibitors for patients with unresectable hepatocellular carcinoma: A propensity score matching study.
    Guo P; Pi X; Gao F; Li Q; Li D; Feng W; Cao W
    Front Oncol; 2022; 12():945915. PubMed ID: 36338683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lenvatinib with or without Concurrent Drug-Eluting Beads Transarterial Chemoembolization in Patients with Unresectable, Advanced Hepatocellular Carcinoma: A Real-World, Multicenter, Retrospective Study.
    Xia D; Bai W; Wang E; Li J; Chen X; Wang Z; Huang M; Huang M; Sun J; Yang W; Lin Z; Wu J; Li Z; Yang S; Zhu X; Chen Z; Zhang Y; Fan W; Mai Q; Ding R; Nie C; Feng L; Li X; Huang W; Sun J; Wang Q; Lv Y; Li X; Luo B; Wang Z; Yuan J; Guo W; Li K; Li B; Li R; Yin Z; Xia J; Han G
    Liver Cancer; 2022 Jul; 11(4):368-382. PubMed ID: 35978600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Promising Preoperative Prediction Model for Microvascular Invasion in Hepatocellular Carcinoma Based on an Extreme Gradient Boosting Algorithm.
    Liu W; Zhang L; Xin Z; Zhang H; You L; Bai L; Zhou J; Ying B
    Front Oncol; 2022; 12():852736. PubMed ID: 35311094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A machine learning-based prediction model pre-operatively for functional recovery after 1-year of hip fracture surgery in older people.
    Lin C; Liang Z; Liu J; Sun W
    Front Surg; 2023; 10():1160085. PubMed ID: 37351328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Machine learning-based models for the prediction of breast cancer recurrence risk.
    Zuo D; Yang L; Jin Y; Qi H; Liu Y; Ren L
    BMC Med Inform Decis Mak; 2023 Nov; 23(1):276. PubMed ID: 38031071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prediction of in-hospital mortality in chronic kidney disease patients with coronary artery disease using machine learning models.
    Ye Z; An S; Gao Y; Xie E; Zhao X; Guo Z; Li Y; Shen N; Ren J; Zheng J
    Eur J Med Res; 2023 Jan; 28(1):33. PubMed ID: 36653875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Machine learning model successfully identifies important clinical features for predicting outpatients with rotator cuff tears.
    Li C; Alike Y; Hou J; Long Y; Zheng Z; Meng K; Yang R
    Knee Surg Sports Traumatol Arthrosc; 2023 Jul; 31(7):2615-2623. PubMed ID: 36629889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Machine learning-based decision support model for selecting intra-arterial therapies for unresectable hepatocellular carcinoma: A national real-world evidence-based study.
    An C; Wei R; Liu W; Fu Y; Gong X; Li C; Yao W; Zuo M; Li W; Li Y; Wu F; Liu K; Yan D; Wu P; Han J
    Br J Cancer; 2024 Sep; 131(5):832-842. PubMed ID: 38971951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Real-World Comparative Analysis of Lenvatinib and Sorafenib as a Salvage Therapy for Transarterial Treatments in Unresectable HCC.
    Lee J; Sung PS; Yang H; Lee SK; Nam HC; Yoo SH; Lee HL; Kim HY; Lee SW; Kwon JH; Jang JW; Kim CW; Nam SW; Bae SH; Choi JY; Yoon SK
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33371271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of Response to Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma by Machine Learning Radiomics: A Multicenter Cohort Study.
    Bo Z; Chen B; Zhao Z; He Q; Mao Y; Yang Y; Yao F; Yang Y; Chen Z; Yang J; Yu H; Ma J; Wu L; Chen K; Wang L; Wang M; Shi Z; Yao X; Dong Y; Shi X; Shan Y; Yu Z; Wang Y; Chen G
    Clin Cancer Res; 2023 May; 29(9):1730-1740. PubMed ID: 36787379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Considerable effects of imaging sequences, feature extraction, feature selection, and classifiers on radiomics-based prediction of microvascular invasion in hepatocellular carcinoma using magnetic resonance imaging.
    Dai H; Lu M; Huang B; Tang M; Pang T; Liao B; Cai H; Huang M; Zhou Y; Chen X; Ding H; Feng ST
    Quant Imaging Med Surg; 2021 May; 11(5):1836-1853. PubMed ID: 33936969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study.
    Chen S; Wu Z; Shi F; Mai Q; Wang L; Wang F; Zhuang W; Chen X; Chen H; Xu B; Lai J; Guo W
    J Cancer Res Clin Oncol; 2022 Aug; 148(8):2115-2125. PubMed ID: 34453221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancing prognostic prediction in hepatocellular carcinoma post-TACE: a machine learning approach integrating radiomics and clinical features.
    Zhang M; Kuang B; Zhang J; Peng J; Xia H; Feng X; Peng L
    Front Med (Lausanne); 2024; 11():1419058. PubMed ID: 39086938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.